Identifying markers for pancreatic cyst progression and early cancer detection
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
['FUNDING_U01'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-11063260
This study is looking at how certain proteins and substances in your blood and pancreatic cyst fluid can help predict if your pancreatic cysts, called IPMNs, might turn into cancer, so we can find better ways to keep an eye on them and take action sooner if needed.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-11063260 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how certain proteins and metabolites in the blood and pancreatic cyst fluid can predict the progression of pancreatic cysts, specifically intraductal papillary mucinous neoplasms (IPMN), into malignant pancreatic cancer. By analyzing samples from patients with IPMN, the study aims to identify specific biomarkers that can indicate whether these cysts are likely to become cancerous. This could lead to improved surveillance strategies and earlier interventions for patients at risk. The research involves a prospective cohort of patients and utilizes advanced proteomic and metabolomic techniques to gather and analyze data over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with intraductal papillary mucinous neoplasms (IPMN) who are being monitored for potential malignant progression.
Not a fit: Patients without pancreatic cysts or those who have already been diagnosed with advanced pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of pancreatic cancer, improving treatment outcomes and survival rates for patients.
How similar studies have performed: Previous research has shown promise in using biomarkers for cancer detection, suggesting that this approach could yield significant insights into pancreatic cancer progression.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCHMIDT, CHRISTIAN MAXIMILLIAN — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: SCHMIDT, CHRISTIAN MAXIMILLIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.